Twitxy Saved

AdvaMed

@AdvaMedUpdate

The leading voice for the medical technology community that provides life-changing innovations to millions of patients every day.
Washington, DC AdvaMed.org Joined February 2009
753 Following 17K Followers 12K Posts

Latest posts 5

AdvaMed @AdvaMedUpdate
Thank you @USAmbIndia for a dynamic discussion on India’s medtech regulatory landscape and opportunities to improve market access for patients. We look forward to continued engagement to advance medtech priorities and strengthen U.S.-India collaboration.
Ambassador Sergio Gor Verified account @USAmbIndia Sep 4
Productive discussion with leading U.S. MedTech companies on unlocking greater opportunities in India. Expanding market access and increasing U.S. exports will strengthen our commercial ties and deepen U.S.-India cooperation in health and medical technology. @AdvaMedUpdate
View quoted post on X
AdvaMed @AdvaMedUpdate
AdvaMed’s 2025 Annual Report is now available. The state of medtech is strong, and the patient impact is undeniable. Millions of lives are improved every day through innovations that enable earlier diagnosis, precise treatment, and minimally invasive care. advamed.org/2025-annual-re…
www.advamed.org 2025 AdvaMed® Annual Report 2025 was a pivotal year for AdvaMed®, the medtech association, championing our member companies' remarkable technologies and the patients they serve.
AdvaMed @AdvaMedUpdate
Agreed. As @ScottWhitakerMD wrote in his recent op-ed, Congress must pass the Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343 / S. 1717) so seniors aren't left waiting years for FDA-authorized breakthrough technologies.

washingtontimes.com/news/2026/feb/……
MAHA Action Verified account @MAHA_Action Feb 26
People are dying and not being treated with up-to-date technology because of bureaucracy in the Medicare system.

Medicare coverage lags years behind FDA approval, meaning people are not getting the treatment they need and deserve.

The safety process for drugs and medical devices needs to be rigorous, but once something is proven safe, there is no reason patients shouldn’t have immediate access.

Lawmakers must act to prevent this from continuing.
View quoted post on X